Ovid Therapeutics secures $81 million in PIPE financing

Ovid Therapeutics has successfully secured $81 million in PIPE financing, a significant boost for the company as it continues to develop innovative treatments for neurological disorders. This funding is crucial as it not only strengthens Ovid's financial position but also enhances its ability to advance its clinical programs, potentially leading to breakthroughs that could benefit many patients. The investment reflects confidence in Ovid's vision and capabilities, marking an important milestone in its growth.